Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy Biotech Investing
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006 Biotech Investing
Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine Pharmaceutical Investing
ContraVir Pharmaceuticals Announces TXL Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population Pharmaceutical Investing
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update Biotech Investing
PRA Health Sciences Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance Pharmaceutical Investing
Isodiol International Inc. Provides Update on Be Tru Wellness, Announces New Distribution Agreement With Threshold Enterprises Cannabis Investing News
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences Pharmaceutical Investing
